Nurix Therapeutics (NRIX) Non-Current Deffered Revenue (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Non-Current Deffered Revenue of $5.97 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 72.4% from $21.64 million a year earlier and down 21.3% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Non-Current Deffered Revenue of $10.01 million, down 61.8% from FY2024.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- Across earlier fiscal years, Non-Current Deffered Revenue came in at $26.21 million in FY2024 (-41.8%), $45.02 million in FY2023 (+25.2%), $35.97 million in FY2022 (-39.0%) and $59.02 million in FY2021 (-2.7%).
- The fiscal Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to fiscal Q4 2019.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for seven consecutive quarters, with an average decline of 22.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 191.5% in fiscal Q3 2024, against a decline of 75.3% in fiscal Q3 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $7.59 million (Q1 2026), $10.01 million (Q4 2025) and $15.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 5.97 Mn |
| Feb 28, 2026 | 7.59 Mn |
| Nov 30, 2025 | 10.01 Mn |
| Aug 31, 2025 | 15.18 Mn |
| May 31, 2025 | 21.64 Mn |
| Feb 28, 2025 | 24.15 Mn |
| Nov 30, 2024 | 26.21 Mn |
| Aug 31, 2024 | 29.86 Mn |
| May 31, 2024 | 38.67 Mn |
| Feb 29, 2024 | 34.46 Mn |
| Nov 30, 2023 | 45.02 Mn |
| Aug 31, 2023 | 10.24 Mn |
| May 31, 2023 | 14.68 Mn |
| Feb 28, 2023 | 26.12 Mn |
| Nov 30, 2022 | 35.97 Mn |
| Aug 31, 2022 | 41.55 Mn |
| May 31, 2022 | 45.86 Mn |
| Feb 28, 2022 | 55.43 Mn |
| Nov 30, 2021 | 59.02 Mn |
| Aug 31, 2021 | 66.38 Mn |
API Access
Nurix Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();